Medication info

Coolite San

Prescription medicationOral
Ingredient · strength
Polyethylene Glycol 3350›50gAnhydrous Sodium Sulfate›3.75gSodium Chloride›1.3455gPotassium Chloride›0.5075gAscorbic Acid›2.35gSodium Ascorbate›2.95g
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
1) A preparation: A white or pale yellow powder with a lemon scent 2) B preparation: White crystals or crystalline powder
Packaging
A preparation: 1 (56.402g) / pouch × 4, B preparation: 1 (5.3g) / pouch × 4
Approval status
Active

MFDS item code 201405897 · Notified 2014.12.15 · Insurance code 671704440

Summary

Main use
Preparation for colon examination through bowel cleansing
Who takes it
Adults
Adult dose
For adults aged 18 years and older, take as described below, either in divided or undivided doses. [Preparation of 500ml of solution] Place 1 sachet of Powder A and 1 sachet of Powder B in a disposable container (500ml), dissolve in an appropriate amount of water, then add more water to the 500mL mark and shake well to prepare a homogeneous solution. Prepare a total of 4 batches of 500ml each. If needed, the solution may be refrigerated before drinking. The prepared solution should be stored refrigerated and used within 24 hours. [Administration] 1) Split-dose regimen: On the evening before colonoscopy, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500ml of water. The next morning, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour, then drink an additional 500ml of water. This process must be completed at least 1 hour before the colonoscopy begins. 2) Non-split-dose (evening) regimen: At around 6 p.m. on the evening before colonoscopy, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour (one 250mL cup every 15 minutes). After 1.5 hours, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour, then drink an additional 1L of water. Coolight Powder should be dissolved in water and prepared, then a total of 2 liters should be taken.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Preparation for colon examination through bowel cleansing

View approved original text

This medicine is used to cleanse the colon before a colonoscopy or X-ray examination. It helps to remove the contents of the colon to ensure that the examination can proceed smoothly. This allows for accurate diagnosis and investigation.

How to take

Adult dose

For adults aged 18 years and older, take as described below, either in divided or undivided doses. [Preparation of 500ml of solution] Place 1 sachet of Powder A and 1 sachet of Powder B in a disposable container (500ml), dissolve in an appropriate amount of water, then add more water to the 500mL mark and shake well to prepare a homogeneous solution. Prepare a total of 4 batches of 500ml each. If needed, the solution may be refrigerated before drinking. The prepared solution should be stored refrigerated and used within 24 hours. [Administration] 1) Split-dose regimen: On the evening before colonoscopy, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500ml of water. The next morning, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour, then drink an additional 500ml of water. This process must be completed at least 1 hour before the colonoscopy begins. 2) Non-split-dose (evening) regimen: At around 6 p.m. on the evening before colonoscopy, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour (one 250mL cup every 15 minutes). After 1.5 hours, take 1L of the prepared solution (2 batches of 500ml solution) over 1 hour, then drink an additional 1L of water. Coolight Powder should be dissolved in water and prepared, then a total of 2 liters should be taken.

Precautions

This medicine may rarely cause systemic tonic-clonic seizures in patients without a history of seizures, so caution is necessary when used with drugs that can cause electrolyte disturbances. It should not be administered to patients with serious gastrointestinal diseases such as bowel obstruction, intestinal closure, perforation, or toxic colitis, and should be used with caution in patients with severe ulcerative colitis. The artificial sweetener aspartame included in this medicine is metabolized to phenylalanine, so patients with phenylketonuria should not take it. This medicine is not to be administered to patients with hypersensitivity to this medicine or its components, suspected bowel obstruction or perforation, dehydration, severe heart failure, active cancer, gastric paralysis, glucose-6-phosphate dehydrogenase deficiency, unconscious patients, or children under the age of 18. Patients with intestinal strictures or severe constipation, the elderly, frail patients, those with vomiting reflex disorders or altered consciousness, and patients with severe renal impairment should be administered cautiously. This medicine may cause adverse reactions such as hunger, hypophosphatemia, hypokalemia, sleep disturbances, dizziness, headache, abdominal pain, nausea, abdominal distension, malaise, thirst, tremors, and discomfort. Particularly in the elderly, serious side effects such as gastrointestinal bleeding due to mucosal damage, esophageal perforation, cardiac asystole, and acute pulmonary edema have been reported, thus caution is needed. Before and during administration of this medicine, the patient's bowel movements and abdominal symptoms should be closely monitored, and if there is severe abdominal distension or pain, the rate of administration should be adjusted or stopped. If symptoms of fluid and electrolyte disturbances appear, blood tests should be done to verify the condition and appropriate treatment should be received. Patients with heart disease or at risk for electrolyte imbalance should undergo monitoring through ECG and blood tests. This medicine may cause diarrhea, so adequate hydration is necessary. Using irritant laxatives in conjunction may increase the risk of intestinal mucosal damage, hence co-administration should be avoided. Before administration, light meals should be taken, and meals should be finished an hour before, avoiding solid foods. The effects of this medicine on driving or operating machinery are unknown but caution is required. Mixing this medicine with thickening agents may reduce viscosity, so caution is needed. It is advisable not to take other medications within 1 hour before this medication is administered, especially those with a narrow therapeutic range may face absorption interference. Women who are pregnant or may become pregnant and breastfeeding mothers should carefully consider the benefits and risks before using this medicine. Safety and efficacy in pediatric patients have not been established, so it is not administered. The elderly should be cautious as they are more sensitive to medications. In case of overdose, dehydration and severe electrolyte disturbances may occur, so symptoms should be closely monitored and necessary treatment should be received. This medicine should not be mixed with other components or flavors, it should be dissolved in water and taken immediately, and any solution not used within 24 hours should be discarded. Keep this medicine out of reach of children, and the prepared solution should be covered and refrigerated without being transferred to another container.

Side effects

Hunger, hypophosphatemia, hypokalemia, sleep disturbances, dizziness, headache, epigastric pain, abdominal pain, nausea, abdominal bloating, rectal discomfort, vomiting, dyspepsia, dysphagia, fatigue, thirst, trembling, malaise, decreased bicarbonate levels in the blood, decreased calcium levels in the blood, hypercalcemia, decreased or increased chloride levels in the blood, increased phosphate levels in the blood, liver dysfunction, rash, urticaria, runny nose, dermatitis, edema, anaphylaxis-like reaction, upper gastrointestinal bleeding due to mucosal damage, esophageal perforation, cardiac arrest, acute pulmonary edema, tachycardia, palpitations, hypertension, arrhythmia, atrial fibrillation, peripheral edema, syncope, dehydration, anaphylaxis reaction, pruritus, lip swelling, tongue swelling, facial swelling, dyspnea, chest tightness, throat tightness, fever, chills, tremors, seizures, renal dysfunction, renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine must be stored in a sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Storing it this way will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

1) A preparation: A white or pale yellow powder with a lemon scent 2) B preparation: White crystals or crystalline powder

Package unit

A preparation: 1 (56.402g) / pouch × 4, B preparation: 1 (5.3g) / pouch × 4

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.